Dai-ichi Life Insurance Company’s Biogen BIIB Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Sell	5,397 -411	-7%	-$78.6K	0.03%	346
2026 Q1	$1.06M	Sell	5,808 -211	-4%	-$38.9K	0.03%	340
2025 Q4	$1.06M	Hold	6,019	–	–	0.03%	363
2025 Q3	$843K	Hold	6,019	–	–	0.02%	392
2025 Q2	$756K	Sell	6,019 -4,700	-44%	-$586K	0.02%	404
2025 Q1	$1.47M	Hold	10,719	–	–	0.04%	310
2024 Q4	$1.64M	Hold	10,719	–	–	0.05%	312
2024 Q3	$2.08M	Hold	10,719	–	–	0.05%	275
2024 Q2	$2.48M	Sell	10,719 -740	-6%	-$161K	0.06%	262
2024 Q1	$2.47M	Hold	11,459	–	–	0.06%	272
2023 Q4	$2.96M	Sell	11,459 -10,222	-47%	-$2.51M	0.06%	247
2023 Q3	$5.57M	Sell	21,681 -2,500	-10%	-$669K	0.12%	156
2023 Q2	$6.89M	Buy	24,181 +10,095	+72%	+$3.01M	0.14%	135
2023 Q1	$3.92M	Hold	14,086	–	–	0.09%	198
2022 Q4	$3.9M	Hold	14,086	–	–	0.09%	198
2022 Q3	$3.76M	Sell	14,086 -3,000	-18%	-$637K	0.09%	189
2022 Q2	$3.48M	Hold	17,086	–	–	0.08%	206
2022 Q1	$3.6M	Hold	17,086	–	–	0.06%	244
2021 Q4	$4.1M	Hold	17,086	–	–	0.05%	249
2021 Q3	$4.83M	Buy	17,086 +685	+4%	+$225K	0.06%	217
2021 Q2	$5.68M	Buy	16,401 +3,848	+31%	+$1.17M	0.07%	202
2021 Q1	$3.51M	Hold	12,553	–	–	0.05%	257
2020 Q4	$3.07M	Hold	12,553	–	–	0.04%	261
2020 Q3	$3.56M	Sell	12,553 -2,641	-17%	-$737K	0.06%	212
2020 Q2	$4.07M	Sell	15,194 -478	-3%	-$144K	0.09%	163
2020 Q1	$4.96M	Buy	15,672 +230	+1%	+$69.8K	0.19%	127
2019 Q4	$4.58M	Sell	15,442 -3,644	-19%	-$1.01M	0.1%	200
2019 Q3	$4.44M	Sell	19,086 -119	-0.6%	-$27.7K	0.11%	205
2019 Q2	$4.49M	Sell	19,205 -4,026	-17%	-$930K	0.11%	202
2019 Q1	$5.49M	Buy	23,231 +66	+0.3%	+$20.8K	0.14%	166
2018 Q4	$6.97M	Sell	23,165 -244	-1%	-$77.9K	0.19%	125
2018 Q3	$8.27M	Sell	23,409 -7,821	-25%	-$2.69M	0.18%	124
2018 Q2	$9.06M	Buy	31,230 +1,432	+5%	+$403K	0.22%	110
2018 Q1	$8.16M	Sell	29,798 -4,236	-12%	-$1.31M	0.17%	130
2017 Q4	$10.8M	Sell	34,034 -507	-1%	-$163K	0.21%	94
2017 Q3	$10.8M	Sell	34,541 -3,098	-8%	-$917K	0.23%	87
2017 Q2	$10.2M	Sell	37,639 -1,247	-3%	-$330K	0.23%	95
2017 Q1	$10.6M	Sell	38,886 -5,564	-13%	-$1.57M	0.29%	81
2016 Q4	$12.6M	Buy	+44,450	New	+$13.2M	0.37%	64

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dai-ichi Life Insurance Company's BIIB Position: Q2 2026 in Review

Dai-ichi Life Insurance Company reduced its Biogen (BIIB) stake by 7.1% in Q2 2026, selling an estimated $78.6K and leaving 5,397 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #346.

Dai-ichi Life Insurance Company first reported a position in BIIB in Q4 2016 and has held it in 39 quarters since. The position peaked at $12.6M in Q4 2016. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Dai-ichi Life Insurance Company held 5,397 shares of Biogen worth $1.17M as of Q2 2026.
Dai-ichi Life Insurance Company sold 411 Biogen shares in Q2 2026, an estimated $78.6K.
Biogen made up 0.03% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #346 holding.
Dai-ichi Life Insurance Company first reported a position in Biogen in Q4 2016 and has held it in 39 quarters since.
Dai-ichi Life Insurance Company's Biogen position peaked at $12.6M in Q4 2016.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.